A prospective long-term confirmatory follow up trial in highly sensitized patients treated with imlifidase or standard of care in the ConfIdeS (20-HMedIdeS-17) trial

Brief description of study

The purpose of this research study is to collect data from patients who have participated in the study ConfIdeS to gather information about kidney function as well as vital (living) status and graft (transplanted organ) survival on a long-term basis, and to confirm the positive benefit-risk balance of imlifidase. No drug will be tested in this study.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.